Vimarsana
Biggest News Aggregation in the World

Page 12 - C Diff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Diff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Diff Today - Breaking & Trending Today

The right combination of bile salt hydrolases may offer a new approach to treat C. diff - Vimarsana News

The right combination of bile salt hydrolases may offer a new approach to treat C. diff

Not all probiotics are created equal. In a new study, researchers found that certain enzymes within a class known as bile salt hydrolases (BSHs) can restrict Clostridioides difficile (C. diff.) colonization by both altering existing bile acids and by creating a new class of bile acids within the gut's microbial environment.

Research reveals how microorganisms found in the gut can worsen C. difficile infections - Vimarsana News

Research reveals how microorganisms found in the gut can worsen C. difficile infections

New research from the University of Virginia School of Medicine and collaborators reveals how microorganisms found in our guts can worsen dangerous C. difficile infections.

Antibiotic-resistant, opportunistic pathogen enhances the pathogenesis of C. difficile - Vimarsana News

Antibiotic-resistant, opportunistic pathogen enhances the pathogenesis of C. difficile

Clostridioides difficile, often referred to as C. difficile or C. diff, is a bacterium that causes severe intestinal illness and, as its name suggests, can be difficult to study and treat.

PLF announces See C. Diff campaign - Vimarsana News

PLF announces See C. Diff campaign

The Peggy Lillis Foundation announced its annual gala to kick off its fourth See C. Diff campaign as part of C. Diff Awareness Month.

Summit Therapeutics Closes Fully-Subscribed $100 Million - Vimarsana News

Summit Therapeutics Closes Fully-Subscribed $100 Million

Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the...